7.36
price up icon1.80%   0.135
 
loading

Cabaletta Bio Inc (CABA) 最新ニュース

Cabaletta Bio Inc (CABA) Stock: Uncovering 52-Week Market Trends - The InvestChronicle

pulisher
The InvestChronicle

A new trading data show Cabaletta Bio Inc (CABA) is showing positive returns. – Sete News - SETE News

pulisher
SETE News

Was anything positive for Cabaletta Bio Inc (CABA) stock last session? – US Post News - US Post News

pulisher
US Post News

Balance Sheet Insights: Cabaletta Bio Inc (CABA)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex

pulisher
The Dwinnex

Balance Sheet Insights: Cabaletta Bio Inc (CABA)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex

pulisher
The Dwinnex

Cabaletta Bio, Inc. (NASDAQ:CABA) Stake Reduced by CHURCHILL MANAGEMENT Corp - Defense World

pulisher
Defense World

Cabaletta Bio (NASDAQ:CABA) Given “Overweight” Rating at Cantor Fitzgerald - Defense World

pulisher
Defense World

Cabaletta Bio's (CABA) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat

pulisher
MarketBeat

An analyst sees good growth prospects for Cabaletta Bio Inc (CABA) – Sete News - SETE News

pulisher
SETE News

Objective long/short (CABA) Report - Stock Traders Daily

pulisher
Stock Traders Daily

What Percentage Of Cabaletta Bio, Inc. (NASDAQ:CABA) Shares Do Insiders Own? - Yahoo Canada Shine On

pulisher
Yahoo Canada Shine On

It would be worthwhile to take a closer look at Cabaletta Bio Inc (CABA) - US Post News

pulisher
US Post News

It would be worthwhile to take a closer look at Cabaletta Bio Inc (CABA) – US Post News - US Post News

pulisher
US Post News

Closing Figures: Cabaletta Bio Inc (CABA)’s Negative Finish at 9.36, Down -12.20 - The Dwinnex

pulisher
The Dwinnex

Cabaletta Bio's (CABA) “Buy” Rating Reaffirmed at Stifel Nicolaus - Defense World

pulisher
Defense World

Citi maintains Buy rating on Cabaletta Bio post-EULAR data By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

Cabaletta Bio (NASDAQ:CABA) Receives Buy Rating from Stifel Nicolaus - MarketBeat

pulisher
MarketBeat

Cabaletta Bio Inc (CABA) Stock: Navigating Drops and Gains - The InvestChronicle

pulisher
The InvestChronicle

Citi maintains Buy rating on Cabaletta Bio post-EULAR data By Investing.com - Investing.com

pulisher
Investing.com

Perceptive Advisors LLC Raises Holdings in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

pulisher
MarketBeat

Perceptive Advisors LLC Purchases 870,567 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

pulisher
MarketBeat

Perceptive Advisors LLC Purchases 870,567 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

pulisher
MarketBeat

Cabaletta Bio (NASDAQ:CABA) Shares Gap Up to $12.56 - Defense World

pulisher
Defense World

Institutional investors in Cabaletta Bio, Inc. (NASDAQ:CABA) lost 18% last week but have reaped the benefits of longer ... - Yahoo Canada Sports

pulisher
Yahoo Canada Sports

Cabaletta Bio's (CABA) Buy Rating Reaffirmed at HC Wainwright - Defense World

pulisher
Defense World

Cabaletta Bio (NASDAQ:CABA) Given "Buy" Rating at HC Wainwright - MarketBeat

pulisher
MarketBeat

Cabaletta Bio (NASDAQ:CABA) Given "Buy" Rating at HC Wainwright - MarketBeat

pulisher
MarketBeat

Cabaletta Bio Reports Promising Early Results for New Autoimmune Disease Treatment - MyChesCo

pulisher
MyChesCo

Cabaletta Bio stock slips on cell therapy data (NASDAQ:CABA) - Seeking Alpha

pulisher
Seeking Alpha

Cabaletta Bio (NASDAQ:CABA) Shares Gap Up to $12.56 - MarketBeat

pulisher
MarketBeat

Did Cabaletta Bio Inc (CABA) perform well in the last session? – US Post News - US Post News

pulisher
US Post News

Cabaletta Bio's Promising Clinical Data Advance Autoimmune Therapy - TipRanks.com - TipRanks

pulisher
TipRanks

Cabaletta Bio (NASDAQ:CABA) Shares Gap Up to $12.56 - MarketBeat

pulisher
MarketBeat

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of CABA-201 - ForexTV.com

pulisher
ForexTV.com

Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ Trials of ... - StockTitan

pulisher
StockTitan

Blackstone Inc. Buys Shares of 347494 Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

pulisher
Defense World

Company’s Banking Stock: Dissecting a -39.92% Quarterly Revenue Decline Amid Growth - The InvestChronicle

pulisher
The InvestChronicle

347,494 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Acquired by Blackstone Inc. - MarketBeat

pulisher
MarketBeat

Financial Metrics Unveiled: Cabaletta Bio Inc (CABA)'s Key Ratios in the Spotlight – DWinneX - The Dwinnex

pulisher
The Dwinnex

Birchview Capital LP Takes $227000 Position in Cabaletta Bio, Inc. (NASDAQ:CABA) - Defense World

pulisher
Defense World

347,494 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Acquired by Blackstone Inc. - MarketBeat

pulisher
MarketBeat

Cabaletta Bio (NASDAQ:CABA) Stock Price Up 16.9% - MarketBeat

pulisher
MarketBeat

Commodore Capital LP Has $43.13 Million Position in Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

pulisher
MarketBeat

Does Cabaletta Bio Inc (CABA) offer a good opportunity for investors? – Sete News - SETE News

pulisher
SETE News

Does Cabaletta Bio Inc (CABA) offer a good opportunity for investors? – Sete News - SETE News

pulisher
SETE News

Cabaletta Bio (NASDAQ:CABA) Stock Price Up 16.9% - MarketBeat

pulisher
MarketBeat

93630 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Bought by TD Asset Management Inc - Defense World

pulisher
Defense World

93,630 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Acquired by TD Asset Management Inc - MarketBeat

pulisher
MarketBeat

93,630 Shares in Cabaletta Bio, Inc. (NASDAQ:CABA) Acquired by TD Asset Management Inc - MarketBeat

pulisher
MarketBeat

Rafferty Asset Management LLC Purchases 91,113 Shares of Cabaletta Bio, Inc. (NASDAQ:CABA) - MarketBeat

pulisher
MarketBeat
$146.84
price down icon 2.64%
$84.97
price down icon 0.08%
$25.73
price down icon 0.16%
$84.20
price down icon 2.90%
$447.85
price down icon 0.91%
$248.02
price up icon 3.29%
大文字化:     |  ボリューム (24 時間):